Education, Science, Technology, Innovation and Life
Open Access
Sign In

Epidemic Characteristics and Control of Acinetobacter Baumannii

Download as PDF

DOI: 10.23977/medsc.2022.030604 | Downloads: 6 | Views: 369

Author(s)

Yuxia Bao 1

Affiliation(s)

1 The Affiliated Hospital of Inner Mongolia Medical University, Huhehot, Mongolia, 010050, China

Corresponding Author

Yuxia Bao

ABSTRACT

Acinetobacter baumannii belongs to Moraceae and Acinetobacter. In the past three decades, Acinetobacter baumannii has gradually developed into a very important hospital infection pathogen, and the number of hospital infection cases and outbreaks caused by this bacterium has gradually increased. Acinetobacter baumannii has a remarkable ability to quickly establish drug resistance mechanisms. Some strains are even resistant to all current antibiotics. The emergence of multi drug resistant strains has caused great difficulties in clinical treatment. In this paper, the epidemiological characteristics of Acinetobacter baumannii infection and its prevention and treatment strategies were reviewed.

KEYWORDS

Acinetobacter baumannii, Epidemic characteristics, Drug resistance mechanism

CITE THIS PAPER

Yuxia Bao, Epidemic Characteristics and Control of Acinetobacter Baumannii. MEDS Clinical Medicine (2022) Vol. 3: 17-21. DOI: http://dx.doi.org/10.23977/medsc.2022.030604.

REFERENCES

[1] Playford E G, Craig J C, Iredell J R. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences.[J]. Journal of Hospital Infection, 2007, 65(3):204-211.
[2] Giamarellou H, Antoniadou A, Kanellakopoulou K. Acinetobacter baumannii: a universal threat to public health? [J]. Int. J. Antimicrob. Agents, 2008, 32(2):106-119.
[3] Runnegar N, Sidjabat H, Goh H, et al. Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii in a Single Institution over a 10-Year Period[J]. Journal of Clinical Microbiology, 2010, 48(11):4051.
[4] Zhou H, Yang Q, Yu Y S, et al. Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China.[J]. Journal of Clinical Microbiology, 2007, 45(12):4054-4057.
[5] Zarrilli R, Pournaras S, Giannouli M, et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages.[J]. International Journal of Antimicrobial Agents, 2013, 41(1):11-19.
[6] Valenzuela J K, Thomas L, Partridge S R, et al. Horizontal Gene Transfer in a Polyclonal Outbreak of Carbapenem-Resistant Acinetobacter baumannii[J]. Journal of Clinical Microbiology, 2007, 45(2):453-460.
[7] Zong Z, X Lü, Valenzuela J K, et al. An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China [J]. International Journal of Antimicrobial Agents, 2008, 31(1):50-54.
[8] Hood M I, Mortensen B L, Moore J L, et al. Identification of an Acinetobacter baumannii Zinc Acquisition System that Facilitates Resistance to Calprotectin-mediated Zinc Sequestration[J]. Plos Pathogens, 2013, 9(12):e1003068.
[9] Hoon L J, Hee C C, Kang H Y, et al. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU[J]. Journal of Antimicrobial Chemotherapy, 2007(4):633-9.
[10] Baran G, Erbay A, Bodur H, et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections[J]. International Journal of Infectious Diseases, 2008, 12(1):16-21.

Downloads: 4543
Visits: 196465

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.